Brief: Cytek Biosciences Announces Pricing Of Its Initial Public Offering
July 23 (Reuters) - Cytek Biosciences Inc CTKB.O :
* CYTEK BIOSCIENCES ANNOUNCES PRICING OF ITS INITIAL PUBLIC
OFFERING
* CYTEK BIOSCIENCES - PRICING OF ITS IPO OF AN AGGREGATE OF
16.75
MILLION SHARES OF ITS COMMON STOCK AT $17 PER SHARE
Source text for Eikon: ID:nGNXbJGlrB
Further company coverage: CTKB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million